Technical Analysis for KRTX - Karuna Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 17.25 -3.04% -0.54
KRTX closed down 3.04 percent on Monday, November 11, 2019, on 57 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical KRTX trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Walk Strength -3.04%
Wide Bands Range Expansion -3.04%
Upper Bollinger Band Touch Strength -3.04%
Upper Bollinger Band Walk Strength -2.87%
Wide Bands Range Expansion -2.87%
Above Upper BB Strength -2.87%
Upper Bollinger Band Touch Strength -2.87%
Shooting Star Candlestick Bearish 1.17%

Older signals for KRTX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily focuses on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical needs. The company's lead product candidate is KarXT, an oral modulator that is in Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia, as well as in Phase Ib clinical trial for the treatment of central nervous system disorders, such as cognitive and negative symptoms, Alzheimer's, and pain. It also focuses on developing other muscarinic-targeted drug candidates. Karuna Pharmaceuticals, Inc. has a license agreement with Eli Lilly and Company; and patent license agreement with PureTech Health LLC. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston, Massachusetts. Karuna Therapeutics, Inc. operates as a subsidiary of PureTech Health plc.
Biopharmaceutical Pain Schizophrenia Central Nervous System Disorders Alzheimer's Treatment Of Central Nervous System Disorders
Is KRTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.0
52 Week Low 11.24
Average Volume 91,734
200-Day Moving Average 0.0
50-Day Moving Average 15.5362
20-Day Moving Average 14.8605
10-Day Moving Average 15.831
Average True Range 1.6246
ADX 22.51
+DI 28.8165
-DI 12.8865
Chandelier Exit (Long, 3 ATRs ) 14.3262
Chandelier Exit (Short, 3 ATRs ) 16.1138
Upper Bollinger Band 18.3587
Lower Bollinger Band 11.3623
Percent B (%b) 0.84
BandWidth 47.080515
MACD Line 0.5968
MACD Signal Line 0.0723
MACD Histogram 0.5245
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.87
Resistance 3 (R3) 18.99 18.57 18.60
Resistance 2 (R2) 18.57 18.16 18.51 18.51
Resistance 1 (R1) 17.91 17.90 17.70 17.79 18.42
Pivot Point 17.49 17.49 17.39 17.43 17.49
Support 1 (S1) 16.83 17.08 16.62 16.71 16.08
Support 2 (S2) 16.41 16.82 16.35 15.99
Support 3 (S3) 15.75 16.41 15.90
Support 4 (S4) 15.63